All lobbying filings
MEHLMAN CONSULTING, INC.
MEHLMAN CONSULTING, INC. filed a Q3 report for VIZIENT INC on October 20, 2026, reporting $60,000 in lobbying income.
Lobbying for VIZIENT INC · Healthcare services company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Texas
Government bodies contacted
2
Lobbying activity
1
340b drug pricing program. Health care workforce. Health care supply chain. Health care drug shortages. H.R. 9599 - SECURE 340B Act - Strengthening the Exercise of Controls and Upgrading Requirements of Efficiency in 340B Act. S. 5244 - SUSTAIN 340B Act - Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act.